Eli Lilly's retatrutide is still in clinical trials. But gym bros are already using a version of the weight-loss drug, amid a ...

New data from Eli Lilly says its daily, oral GLP-1 pill may help people who have obesity and people who have Type 2 diabetes ...

Eli Lilly and Company (NYSE:LLY)’s shares have become one of the most valuable in the sector due to its strong presence in the weight loss drug industry.

Eli Lilly's orforglipron outshines Novo Nordisk's oral semaglutide with efficacy & scalability, promising growth in the ...

Eli Lilly (LLY) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some ...

Eli Lilly and Company (NYSE: LLY) is one of the stocks that Jim Cramer shared insight on. A caller inquired about the company, noting its recent approval for a memory loss treatment. Cramer replied: ...

With Wall Street still enthralled by tech and AI stocks, Eli Lilly is a speculative play with plenty of benefits to be reaped from diversification. While it's important to keep an ear to the ground in ...

In a Phase 3 trial, drugmaker Eli Lilly and Company said it's oral GLP-1 pill showed similar results to injectable weight ...

Eli Lilly is "confident" it can reach the 750 job number it stated in December after an agreement with the state provides tax credits for 560 jobs.

Eli Lilly (LLY) stock soars as its weight loss therapy advances in trials. Learn how top pharma stocks compare, backed by ...

Eli Lilly announced this week that its new weight-loss pill, orforglipron, cleared its latest Phase 3 trial, bringing it ...

Eli Lilly has temporarily paused shipments of its weight-loss drug Mounjaro in the UK, ahead of a new price hike for the ...